---
sidebar_position: 24
---

# æ–‡ç» 24ï¼šArtificial intelligence for detecting anaphylaxis in electronic medical records

**English Title**: Artificial intelligence for detecting anaphylaxis in electronic medical records

**ä¸­æ–‡æ¨™é¡Œ**: ç”¨æ–¼åœ¨é›»å­ç—…æ­·ä¸­æª¢æ¸¬éæ•æ€§ä¼‘å…‹çš„äººå·¥æ™ºèƒ½
**PMID**: 40933427
**æœŸåˆŠ**: Asia Pacific allergy
**è©•åˆ†**: 7
**æ‡‰ç”¨é ˜åŸŸ**: é–€è¨º
**DOI**: https://doi.org/10.5415/apallergy.0000000000000179

---

## ğŸ“Œ ç¬¬ä¸€å¼µï¼šæ ¸å¿ƒè§€é»å¡

### ä¸»è¦ç™¼ç¾
EMRä¸­è‡ªå‹•åŒ–éæ•æ€§ä¼‘å…‹æª¢æ¸¬

### æ–‡ç»æ‘˜è¦ï¼ˆAbstractï¼‰
BACKGROUND: Despite established criteria, diagnosing anaphylaxis remains challenging but critical for preventing future reactions. Fast-paced clinical settings, compounded by underrecording in electronic medical records (EMRs), increase the risk of dangerous re-exposures. Leveraging artificial intelligence through automated systems such as large language models (LLMs) offers a solution. OBJECTIVE: This study aims to assess the efficacy of artificial intelligence, specifically LLMs, in autonomously identifying anaphylaxis diagnoses from EMR text to enhance patient safety and optimize care delivery. METHODS: LLMs (GPT 3.5, 4, and 4 Turbo) analyzed 969 medical texts in Brazilian Portuguese, annotated as anaphylaxis-positive (48) or negative (921) by 3 expert physicians. A primary prompt simulated a general practitioner's role in reviewing medical narratives for anaphylaxis detection, with a secondary prompt incorporating World Allergy Organization (WAO) criteria. The experiments were conducted using 3 GPT configurations. The diagnostic suggestions of the LLM were compared to the physicians' diagnoses. Precision, sensitivity (recall), specificity, and accuracy values were calculated. RESULTS: Using the primary prompt, GPT 4 Turbo detected anaphylaxis cases with 90.6% precision, 100% sensitivity, 99.5% specificity, 99.5% accuracy, and a Cohen kappa coefficient of 0.95. The inclusion of WAO criteria slightly improved the performance of older models (GPT 3.5 + 4 configuration). However, for GPT 4 Turbo, additional information did not enhance precision. CONCLUSION: The results highlight the potential of artificial intelligence, particularly LLMs, to automate anaphylaxis diagnosis, support healthcare professionals, and improve patient safety and care.

### ä¸­æ–‡æ‘˜è¦
èƒŒæ™¯ï¼šå„˜ç®¡å·²æœ‰æ—¢å®šæ¨™æº–ï¼Œéæ•æ€§ä¼‘å…‹çš„è¨ºæ–·ä»ç„¶å…·æœ‰æŒ‘æˆ°æ€§ï¼Œä½†å°æ–¼é é˜²æœªä¾†åæ‡‰è‡³é—œé‡è¦ã€‚å¿«ç¯€å¥çš„è‡¨åºŠç’°å¢ƒï¼ŒåŠ ä¸Šé›»å­ç—…æ­·ï¼ˆEMRï¼‰è¨˜éŒ„ä¸è¶³ï¼Œå¢åŠ äº†å±éšªå†æ¬¡æš´éœ²çš„é¢¨éšªã€‚é€éè‡ªå‹•åŒ–ç³»çµ±ï¼ˆå¦‚å¤§å‹èªè¨€æ¨¡å‹ï¼ŒLLMï¼‰é‹ç”¨äººå·¥æ™ºæ…§æä¾›äº†è§£æ±ºæ–¹æ¡ˆã€‚ç›®çš„ï¼šæœ¬ç ”ç©¶æ—¨åœ¨è©•ä¼°äººå·¥æ™ºæ…§ï¼Œç‰¹åˆ¥æ˜¯ LLMï¼Œåœ¨å¾ EMR æ–‡æœ¬ä¸­è‡ªä¸»è­˜åˆ¥éæ•æ€§ä¼‘å…‹è¨ºæ–·çš„æ•ˆèƒ½ï¼Œä»¥å¢å¼·æ‚£è€…å®‰å…¨ä¸¦å„ªåŒ–ç…§è­·æä¾›ã€‚æ–¹æ³•ï¼šLLMï¼ˆGPT 3.5ã€4 å’Œ 4 Turboï¼‰åˆ†æäº† 969 ä»½å·´è¥¿è‘¡è„ç‰™èªé†«ç™‚æ–‡æœ¬ï¼Œç”± 3 ä½å°ˆå®¶é†«å¸«æ¨™è¨»ç‚ºéæ•æ€§ä¼‘å…‹é™½æ€§ï¼ˆ48 ä¾‹ï¼‰æˆ–é™°æ€§ï¼ˆ921 ä¾‹ï¼‰ã€‚ä¸»è¦æç¤ºæ¨¡æ“¬å…¨ç§‘é†«å¸«å¯©æŸ¥é†«ç™‚æ•˜è¿°ä»¥æª¢æ¸¬éæ•æ€§ä¼‘å…‹çš„è§’è‰²ï¼Œæ¬¡è¦æç¤ºç´å…¥ä¸–ç•Œéæ•çµ„ç¹”ï¼ˆWAOï¼‰æ¨™æº–ã€‚å¯¦é©—ä½¿ç”¨ 3 ç¨® GPT é…ç½®é€²è¡Œã€‚å°‡ LLM çš„è¨ºæ–·å»ºè­°èˆ‡é†«å¸«è¨ºæ–·é€²è¡Œæ¯”è¼ƒã€‚è¨ˆç®—ç²¾ç¢ºåº¦ã€æ•æ„Ÿåº¦ï¼ˆå¬å›ç‡ï¼‰ã€ç‰¹ç•°åº¦å’Œæº–ç¢ºåº¦å€¼ã€‚çµæœï¼šä½¿ç”¨ä¸»è¦æç¤ºï¼ŒGPT 4 Turbo æª¢æ¸¬éæ•æ€§ä¼‘å…‹ç—…ä¾‹çš„ç²¾ç¢ºåº¦ç‚º 90.6%ï¼Œæ•æ„Ÿåº¦ç‚º 100%ï¼Œç‰¹ç•°åº¦ç‚º 99.5%ï¼Œæº–ç¢ºåº¦ç‚º 99.5%ï¼ŒCohen kappa ä¿‚æ•¸ç‚º 0.95ã€‚ç´å…¥ WAO æ¨™æº–å¾Œï¼ŒèˆŠæ¨¡å‹ï¼ˆGPT 3.5 + 4 é…ç½®ï¼‰çš„æ€§èƒ½ç•¥æœ‰æ”¹å–„ã€‚ç„¶è€Œï¼Œå°æ–¼ GPT 4 Turboï¼Œé¡å¤–è³‡è¨Šä¸¦æœªæå‡ç²¾ç¢ºåº¦ã€‚çµè«–ï¼šçµæœçªé¡¯äº†äººå·¥æ™ºæ…§ï¼Œç‰¹åˆ¥æ˜¯ LLMï¼Œåœ¨è‡ªå‹•åŒ–éæ•æ€§ä¼‘å…‹è¨ºæ–·ã€æ”¯æŒé†«ç™‚å°ˆæ¥­äººå“¡ä»¥åŠæ”¹å–„æ‚£è€…å®‰å…¨å’Œç…§è­·æ–¹é¢çš„æ½›åŠ›ã€‚

### é—œéµæ•¸æ“š
- **ç ”ç©¶é¡å‹**: æœªåˆ†é¡
- **åœ‹å®¶/åœ°å€**: å¾…æŸ¥
- **ç™¼è¡¨å¹´ä»½**: å¾…æŸ¥
- **ROI æ•¸å€¼**: ç„¡æ•¸å€¼

### æ ¸å¿ƒå‰µæ–°é»
æœ¬ç ”ç©¶çš„ä¸»è¦å‰µæ–°åœ¨æ–¼ï¼šEMRä¸­è‡ªå‹•åŒ–éæ•æ€§ä¼‘å…‹æª¢æ¸¬

---

## âœï¸ ç¬¬äºŒå¼µï¼šParaphrase å¡

### ç ”ç©¶ç›®çš„èˆ‡æ–¹æ³•
æœ¬ç ”ç©¶èšç„¦æ–¼é–€è¨ºé ˜åŸŸï¼Œæ—¨åœ¨æ¢è¨ AI æŠ€è¡“åœ¨é†«ç™‚å ´æ™¯ä¸­çš„æ‡‰ç”¨ã€‚

### ä¸»è¦è²¢ç»
ç ”ç©¶æå‡ºäº†EMRä¸­è‡ªå‹•åŒ–éæ•æ€§ä¼‘å…‹æª¢æ¸¬ï¼Œç‚ºè‡¨åºŠå¯¦è¸æä¾›äº†æ–°çš„è§£æ±ºæ–¹æ¡ˆã€‚

### æŠ€è¡“ç‰¹é»
- æ‡‰ç”¨å ´æ™¯ï¼šé–€è¨º
- å‰µæ–°ç¨‹åº¦ï¼šè©•åˆ† 7/10
- æœŸåˆŠå½±éŸ¿ï¼šç™¼è¡¨æ–¼ Asia Pacific allergy

---

## â“ ç¬¬ä¸‰å¼µï¼šå•ç­”å¡

### Q1: é€™é …ç ”ç©¶è§£æ±ºäº†ä»€éº¼å•é¡Œï¼Ÿ
A: æœ¬ç ”ç©¶é‡å°é–€è¨ºé ˜åŸŸçš„æŒ‘æˆ°ï¼Œæå‡ºäº†åŸºæ–¼ AI çš„è§£æ±ºæ–¹æ¡ˆã€‚

### Q2: æ¡ç”¨äº†ä»€éº¼æŠ€è¡“æ–¹æ³•ï¼Ÿ
A: EMRä¸­è‡ªå‹•åŒ–éæ•æ€§ä¼‘å…‹æª¢æ¸¬

### Q3: ç ”ç©¶çš„ä¸»è¦æˆæœæ˜¯ä»€éº¼ï¼Ÿ
A: ç ”ç©¶ç²å¾—äº† 7 åˆ†çš„å°ˆå®¶è©•åˆ†ï¼Œè­‰æ˜äº†å…¶åœ¨é–€è¨ºé ˜åŸŸçš„æ‡‰ç”¨åƒ¹å€¼ã€‚

### Q4: æœ‰å“ªäº›å¯¦éš›æ‡‰ç”¨å ´æ™¯ï¼Ÿ
A: ä¸»è¦æ‡‰ç”¨æ–¼é–€è¨ºï¼Œå¯ç”¨æ–¼æ”¹å–„é†«ç™‚æœå‹™å“è³ªå’Œæ•ˆç‡ã€‚

---

## ğŸ¤” ç¬¬å››å¼µï¼šä¾‹å¤–å¡

### æ½›åœ¨é™åˆ¶
1. **ç ”ç©¶ç¯„åœ**: ç ”ç©¶è©•åˆ†ç‚º 7/10ï¼Œå¯èƒ½å­˜åœ¨æ”¹é€²ç©ºé–“
2. **åœ°å€å·®ç•°**: ç ”ç©¶ä¾†è‡ªå¾…æŸ¥ï¼Œå…¶ä»–åœ°å€é©ç”¨æ€§éœ€é©—è­‰
3. **ROI æ•¸æ“š**: ç„¡æ•¸å€¼ï¼Œç¶“æ¿Ÿæ•ˆç›Šè©•ä¼°å¯èƒ½ä¸å®Œæ•´

### éœ€è¦é€²ä¸€æ­¥æ¢è¨çš„å•é¡Œ
1. è©²æŠ€è¡“åœ¨ä¸åŒè¦æ¨¡é†«é™¢çš„é©ç”¨æ€§å¦‚ä½•ï¼Ÿ
2. é•·æœŸä½¿ç”¨çš„æ•ˆæœå’Œç©©å®šæ€§æ˜¯å¦ç¶“éé©—è­‰ï¼Ÿ
3. èˆ‡ç¾æœ‰ç³»çµ±æ•´åˆæ™‚å¯èƒ½é¢è‡¨å“ªäº›æŒ‘æˆ°ï¼Ÿ

### æ‰¹åˆ¤æ€§æ€è€ƒ
- **æŠ€è¡“æˆç†Ÿåº¦**: éœ€è¦è©•ä¼°å¾ç ”ç©¶åˆ°å¯¦éš›éƒ¨ç½²çš„è·é›¢
- **æˆæœ¬æ•ˆç›Š**: ç„¡æ•¸å€¼ï¼Œéœ€è¦æ›´è©³ç´°çš„ç¶“æ¿Ÿåˆ†æ
- **å€«ç†è€ƒé‡**: AI åœ¨é–€è¨ºæ‡‰ç”¨æ™‚çš„å€«ç†å’Œéš±ç§å•é¡Œ
- **å¯æ¨å»£æ€§**: ç ”ç©¶çµæœåœ¨å…¶ä»–é†«ç™‚å ´æ™¯çš„é©ç”¨æ€§

---

## ğŸ“š åƒè€ƒè³‡è¨Š
- **PMID**: [40933427](https://pubmed.ncbi.nlm.nih.gov/40933427/)
- **DOI**: https://doi.org/10.5415/apallergy.0000000000000179
- **æœŸåˆŠ**: Asia Pacific allergy
